Introduction
============

Porcine reproductive and respiratory syndrome (PRRS), caused by PRRS virus (PRRSV) which belongs to the genus *Arterivirus* of the family *Arteriviridae*, is the most economically significant disease effecting commercially bred pigs world-wide [@B1]. This disease is characterized by anorexia, increased late-term abortions, increased number of stillborn pigs, mummified fetuses, weak live-born piglets, increased pre-weaning mortality, and delayed return to estrus [@B2]. *In vivo*, PRRSV productive infection occurs predominately in alveolar macrophages of the lung [@B3], followed by viremia and subsequent interstitial pneumonia within 3 days [@B4]. It was hypothesized that respiratory pathology, especially lung damage during PRRSV infection, results from an overproduction of pro-inflammatory cytokines in the lungs [@B5].

Genome-wide transcriptional responses of lungs of Landrace×Yorkshire crossbred piglets to a classical North American type PRRSV strain infection was analyzed by Solexa/Illumina\'s Digital Gene Expression (DGE) System, which is a tag-based high-throughput transcriptome sequencing method [@B6]. This systematic analysis of the pulmonary gene expression profiles suggested that upregulation expression of pro-inflammatory cytokines, chemokines, adhesion molecules and inflammatory enzymes and inflammatory cells, antibodies, complement activation were likely to result in the development of inflammatory responses during PRRSV infection processes [@B6]. Another high-throughput deep sequencing was performed focusing on the pulmonary gene expression profiles after a highly pathogenic-PRRSV (HP-PRRSV) strain infection [@B7]. The system analysis of the pulmonary gene expression provides a comprehensive basis for better understanding the pathogenesis of HP-PRRSV [@B7]. Because PRRSV infection occurs predominately in porcine alveolar macrophages (PAMs) [@B3], the interaction between PRRSV and PAMs have been studied systematically by high-throughput research methods *in vitro*. PAMs, lavaged from six piglets, were challenged with the Lelystad PRRSV strain *in vitro*, and the gene expression of the PAMs was investigated using Affymetrix microarrays [@B8]. The result suggested that the expression of beta interferon 1 (*IFN-β*), but not of *IFN-α*, was strongly upregulated in the early stage of PRRSV infection [@B8]. Besides microarray, Serial Analysis of Gene Expression (SAGE) was also employed to examine the global expression of genes in PRRSV-infected PAMs *in vitro* [@B9]. These studies have provided global gene expression profiles of lung tissue *in vivo* and PAMs *in vitro* following infection with PRRSV; however, transcriptome-wide understanding of the interaction between PRRSV and PAMs *in vivo* has not yet been established.

In 2006, an unparalleled large-scale outbreak of highly pathogenic PRRS (HP-PRRS) occured in many areas of China. This outbreak affected more than 2 millions pigs and produced approximately 0.4 million fatal cases [@B10]. In this study, laboratory infection was performed in Tongcheng piglets (a Chinese indigenous breed living in Tongcheng county of Hubei province) using PRRSV stain WUH3 [@B11], a highly pathogenic PRRSV isolated in China during the pandemic period of HP-PRRS in 2006. We also employed Affymetrix microarrays to investigate the gene expression patterns of PAMs isolated from the piglets after infection. The current study aims at better understanding the interaction between HP-PRRSV and the host PAMs, which may lead to the identification of key host factors for tolerance/susceptibility to the virus and the finding of novel targets for antiviral therapies.

Materials and methods
=====================

Animals and experimental design
-------------------------------

All animal procedures were performed according to protocols approved by the Biological Studies Animal Care and Use Committee of Hubei Province, China. Piglets used in this study were free from PRRSV, pseudorabies virus (PRV) and porcine circovirus type 2 (PCV2) determined by ELISA test for serum antibodies. Twelve 5-week-old Tongcheng boars (a Chinese indigenous breed) were obtained from three litters (four piglets per litter), and raised in pathogen-free facilities. To perform a paired experiment, individuals within a full-sib litter were separated into two groups: one infected group and one control group with 6 piglets in each group. The infected groups were challenged with PRRSV-WUH3 (3 ml/15 kg, 10^-5^ TCID~50~/ml) by intramuscular inoculation. Slaughters were carried out at 0 day post-infection (dpi) for uninfected (control) groups, and at 5 or 7 dpi for infected groups. Rectal temperature and clinical signs were recorded daily during the experiment. The serum samples for viremia detection were collected daily from all animals (one ml blood per sampling point). The PAMs for microarray analysis were collected by bronchoalveolar lavage from three uninfected pigs and three infected pigs at 5 dpi.

Gross and microscopic lung lesions
----------------------------------

Post-mortem examinations were performed on all pigs. Macroscopic lung lesions were given a subjective score to estimate the percentage of the lung affected by pneumonia, following a scoring system described previously [@B12], [@B13]. For histopathology analysis, samples of the apical segment of the lower lung lobes were collected and fixed in 4% paraformalclehyde for 24 h. Fixed samples were dehydrated, embedded in paraffin, sectioned into 4 μm and stained with hematoxylin and eosin. Sections were examined by light microscopy.

Viral load determination
------------------------

For viremia detection, serum samples were collected daily from all pigs. Total viral RNA was extracted from 200 μl serum using TRIzol Reagent (Invitrogen, Carlsbad, CA). cDNA was synthesized using oligo(dT)15 primer, M-MLV Reverse Transcriptase (Promega, Madison, WI) in 50 μl reaction mixture according to the manufacturer\'s instructions. Absolute quantitative-PCR (Q-PCR) was performed using primers specific to the ORF7 of PRRSV (sense: 5\'-TCA GCT GTG CCA AAT GCT GG-3\'; antisense: 5\'-AAA TGG GGC TTC TCC GGG TTT T-3\'). For absolute quantification, the pET-18M plasmid of the known copy number containing the ORF7 fragment generated standard curve. Viral copies per ml of the unknown samples were determined by linear extrapolation of the Ct value plotted against the standard curve [@B14].

RNA extraction and microarray hybridization
-------------------------------------------

TRIzol (Invitrogen) was used for RNA extractions following the manufacturer\'s instructions. RNA integrity and concentration were evaluated by denaturing formaldehyde gel electrophoresis and Agilent 2100 Bioanalyzer. The RNA samples were sent to GeneTech Biotechnology Limited Company (Shanghai, China) for hybridization to the porcine Affymetrix GeneChip (Affymetrix, Santa Clara, CA). A total of 6 microarray analyses were conducted using the procedure described previously [@B15].

Microarray data analysis
------------------------

The raw data (Affymetrix GeneChip Scanner 3000) was converted to gene signal files by MAS 5.0 (Microarray Suite Version 5.0, Affymetrix). The data points were normalized between slides using the quantile normalization method used by Bolstad et al. [@B16]. The differentially expressed genes were selected using the SAM (Significance Analysis of Microarrays) package (<http://www-stat.stanford.edu/~tibs/SAM/>), and the false discovery rate (FDR) values were generated using permutations of the repeated measurements to estimate the percentage of genes identified by chance. In the experiment, SAM settings were adjusted for a two class paired analysis, using one hundred permutations to calculate the differentially expressed gene list. The fold-change of 1.5 and a false discovery rate of approximately 5% were set as a threshold. All data are MIAME compliant and have been deposited in NCBI\'s Gene Expression Omnibus and are accessible through GEO Series accession number GSE22782 (<http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE22782>). Differential gene expressions were performed for hierarchical cluster (Ver.3.0) and TreeView (Ver.1.60) analyses [@B17]. The functional annotation of differentially expressed genes was performed by the DAVID (The Database for Annotation, Visualization and Integrated Discovery) gene annotation tool (<http://david.abcc.ncifcrf.gov/>) [@B18], as well as by referring to a previous work [@B19].

Q-PCR
-----

The RNA samples prepared for microarray analysis were also used for Q-PCR verification. Reverse transcriptions were performed using M-MLV Reverse Transcriptase (Promega) according to the manufacturer\'s instructions. The primers were designed with the Primer Premier 5.0 program. The *RPL32* gene was used as the internal control [@B20]. The primer sequences, melting temperatures and product sizes are shown in Table [1](#T1){ref-type="table"}. Q-PCR was performed on the LightCycler 480Ⅱ (Roche, Basel, Sweden) using SYBR Green Realtime PCR Master Mix (TOYOBO CO., LTD, Japan) as the readout. Data was analyzed by the 2^-ΔΔCT^ method [@B21]. The data analysis procedure was performed as described previously [@B15].

Results
=======

Clinical and pathological features of HP-PRRSV-infected piglets
---------------------------------------------------------------

After infection with PRRSV-WUH3, the piglets presented typical clinical signs, e.g. fever, asthma, coughing, anorexia, lethargy and convulsion. The average rectal temperature rose to above 40.5 ºC at 2 dpi and seemed to peak at 5 dpi. The two piglets surviving at 5 dpi showed a slight decrease of rectal temperature in the following two days (Figure [1](#F1){ref-type="fig"}A). To assess the replication and spread of HP-PRRSV, the viral copy number/ml in serum was determined by absolute real-time quantitative-PCR (Figure [1](#F1){ref-type="fig"}B). The level of viremia increased rapidly during the first two days post-infection, then increased slowly from 3 to 5 dpi, and approached the plateau phase at 6 or 7 dpi.

Pathologic examination was carried out on the animals. Macroscopic examination detected a mild lung lesion at the apical segment of the lower lobes at 5 and 7 dpi (Figure [1](#F1){ref-type="fig"}C). For estimating the severity of the pneumonia, gross lung lesion scores were made based on the method described previously [@B12], [@B13]. The low scores indicated a mild regional lung damage at 5 and 7 days after HP-PRRSV infection (Figure [1](#F1){ref-type="fig"}D). As compared with the uninfected group (Figure [1](#F1){ref-type="fig"}E), microscopic examination detected a certain extent of congestion as well as interstitial infiltration of leukocytes in the lungs of infected piglets (Figure [1](#F1){ref-type="fig"}F).

Transcriptome analysis of the virus-host cell interaction in vivo
-----------------------------------------------------------------

PAMs samples collected from three infected piglets at 5 dpi and three uninfected piglets were analyzed. A total of 12,775 transcripts (53% of all probesets) were expressed in infected and non-infected PAMs ([Supplementary Table 1](#ST1){ref-type="supplementary-material"}). After quantile normalization, 321 genes were identified as differentially expressed (DE) genes, with 219 being upregulated and 102 being downregulated, under the threshold of fold change (FC) of 1.5 or greater and a false discovery rate (FDR) of approximately 5% (Figure [2](#F2){ref-type="fig"}A and [Supplementary Table 2](#ST2){ref-type="supplementary-material"}).

Based on the Database for Annotation, Visualization and Integrated Discovery (DAVID), 166 of the DE genes were classified into 47 categories, many of which shared the same genes, according to their functional correlation (Figure [2](#F2){ref-type="fig"}B and [Supplementary Table 3](#ST3){ref-type="supplementary-material"}). The majority of the genes related to the virus-host cell interaction could be assigned into the categories including cell death and apoptosis related, response to wounding, response to unfolded protein, response to oxidative stress, response to virus, innate immune response, response to cytokine stimulus, and endoplasmic reticulum (ER) overload response. Other DE genes that were not classified by DAVID were taken into account for further analysis below.

Sensing the HP-PRRSV infection by PAMs
--------------------------------------

In macrophages, PRRSV entry into the host cell is mediated by heparan sulphate proteoglycans and the receptor sialoadhesin. Upon a pH drop, PRRSV is uncoated and its genome is released from the endosomes into the cytoplasm, which allows virus replication [@B22]. After HP-PRRSV infection the *ATP6V1B2* gene, which encodes a component of vacuolar ATPase (V-ATPase) that mediates acidification of endosomal organelles [@B23], was upregulated (Figure [3](#F3){ref-type="fig"}). *SARM1*, a negative regulator of TRIF-dependent Toll-like receptor (TLR) signaling [@B24] and MAPK phosphorylation [@B25], was significantly downregulated (Figure [3](#F3){ref-type="fig"}). *SBNO2*, a potent inhibitor of NF-κB [@B26], and *SOCS1* which limits NF-κB signaling by decreasing p65 stability within the cell nucleus [@B27], were upregulated (Figure [3](#F3){ref-type="fig"}). Upon HP-PRRSV infection, *IRF7* was found to be upregulated in PAMs at 5 dpi (Figure [3](#F3){ref-type="fig"}), however, no type-I IFN or IFN-γ induction was observed. A number of IFN-induced genes (*IFI6*, *IFI16*, *IFIH1*, *IFIT2*, *IFIT3*, *IFITM3*, *GBP1*, *GBP2*, *MX1*, *GZMB*, *GZMH*, *ISG15*, *USP18*, *RSAD2*, *NMI*) were upregulated (Table [2](#T2){ref-type="table"}). JAK-STAT pathway seemed to be positively (*STAT1* and *NMI*) as well as negatively (*SOCS1*) regulated during HP-PRRSV infection (Figure [3](#F3){ref-type="fig"}).

Cytoskeleton and exocytosis organization in PAMs
------------------------------------------------

Nine genes (*S100A6*, *MARCKS*, *CACYBP*, *CCT6A*,*ARHE*, *CCT3*, *PTPN4*, *CCT7*, and *TWF1*) related to actin and tubulin cytoskeleton organization were upregulated and three (*RASSF8*, *ELMO1*, and *KIF11*) were downregulated (Table [3](#T3){ref-type="table"}). In addition, several exocytosis related genes (*RSAD2*, *GSK3B*, *LMAN2L*, *EXOC2*, *SELS*, *COPZ2*, *SEC31L2*, and *SEC8L1*) were differentially expressed in PAMs after HP-PRRSV infection (Table [3](#T3){ref-type="table"}). *RSAD2*, encoding an IFN-induced protein which inhibits influenza A virus release from the plasma membrane of infected cells by affecting the formation of lipid rafts [@B28], was upregulated significantly. Vesicle trafficking between the Golgi apparatus and ER seemed to be restricted, because COPZ2, a member of the COPI coat which helps vesicles transport proteins from the cis end of the Golgi complex back to the rough ER [@B29], and SEC31L2, a component of the COPII vesicle coat that mediates vesicular traffic from the rough ER to the Golgi apparatus [@B30], were both downregulated.

Protein degradation and folding in PAMs
---------------------------------------

During HP-PRRSV infection, homeostasis of ISGylation, an ubiquitin-like modification, seemed to be re-established in PAMs by enhancing the expression of ISG15, an ubiquitin-like protein, and USP18, which is an ISG15 deconjugating protease (Table [3](#T3){ref-type="table"}). Three E3 ubiquitin ligase genes (*CACYBP*, *HERC6*, *CUL1*) were upregulated, and two (*HERC3*, *G2E3*) were downregulated (Table [3](#T3){ref-type="table"}). As expected, a large set of chaperone genes were upregulated, including heat shock 40 kDa protein (Hsp40) (*DNAJA1*, *DNAJA4*, *DNAJB1*, *DNAJB2*, and *DNAJB4*), Hsp60 (*HSPD1*), Hsp70 (*HSPA1B*, *HSPA4*, *HSPA4*, and *HSPA6*), Hsp105/110 (*HSPH1*), and subunits of chaperon in containing t-complex polypeptide 1 (*CCT3*, *CCT7*, and *CCT6A*), as well as *NPM3*, a molecular chaperone in the cell nucleus (Table [3](#T3){ref-type="table"}).

Intracellular calcium and zinc homeostasis in PAMs
--------------------------------------------------

Upon HP-PRRSV infection, several DE genes were involved in the intracellular calcium homeostasis in PAMs (Table [3](#T3){ref-type="table"}). After HP-PRRSV infection, zinc ion concentration in PAMs seemed to be increased, through upregulating the expression of *SLC39A14* which encodes a zinc influx transporter [@B31] (Table [3](#T3){ref-type="table"}). Several zinc finger protein encoding genes (*ZDHHC9*, *ZFAND2A*, *ZCCHC6*, *ZCWPW1*, *ZFP2*, *ZNF258*) were also identified as DE genes, and all of them were upregulated, except *ZNF258* (Table [3](#T3){ref-type="table"}).

Tissue remolding and inflammation
---------------------------------

During HP-PRRSV infection, a set of DE genes involved in the dynamic regulation of the extracellular matrix and vascular permeability was identified (Table [4](#T4){ref-type="table"}). Infiltration of leukocytes into pulmonary alveoli, as a sign of inflammation, was modulated by upregulating a small number of genes (*CCL2*, *CCL4L*, *CCR5* and *CSF1*) (Table [4](#T4){ref-type="table"}). Three genes, *MPP1*, *PF4*, and *PPBP* involved in neutrophil infiltration or activation [@B32]-[@B34], were all downregulated (Table [4](#T4){ref-type="table"}). During HP-PRRSV infection, complement activation seemed to be inhibited, as expression of *C3* and *PFC*, a positive regulator of complement activation, were downregulated, and *CLU*, encoding for a complement inhibitor, was upregulated (Table [4](#T4){ref-type="table"}).

Confirmation of differential expression by Q-PCR
------------------------------------------------

Seven genes (*CCL2*, *SLC39A14*, *ATP6V1B2*, *C3*, *DDIT3*, *GLRX2* and *TNF*) were selected for Q-PCR assay to validate the changes in gene expression observed by microarray analysis. *CCL2* was the main upregulated chemokine gene in this study (Table [4](#T4){ref-type="table"}). Two upregulated genes,*SLC39A14* and *ATP6V1B2,*were involved in intracellular zinc homeostasis and endosome acidification, respectively. The downregulated *C3* gene is the core member of the complement system which seemed to be inhibited, according to our study (Table [4](#T4){ref-type="table"}). The Q-PCR gene list also contained two DE genes (*DDIT3*, *GLRX2*) which were not referred to in the discussion, and *TNF*, an important cytokine gene, which was not differentially expressed in Tongcheng PAMs in response to HP-PRRSV infection. The changes of these genes, detected by microarray analysis, was in agreement with the Q-PCR validation (Figure [4](#F4){ref-type="fig"}).

Discussion
==========

The results of this study showed that Tongcheng piglets exhibited typical clinical signs following infection with HP-PRRSV WUH3 strain. The lung damage caused by the infection was regional and mild at 5 and 7 dpi (Figure [1](#F1){ref-type="fig"}C and D), but further observation for a longer period of time was not performed in this study. The slow reproduction rate of the virus (viremia) at 3 to 7 dpi (Figure [1](#F1){ref-type="fig"}B) suggested a near balance between the viral replication and the defense mechanisms in the PAMs. Transcriptomic analysis of the PAMs at 5 dpi identified 321 DE genes under the filter of 1.5-fold change, and the number of upregulated genes (219) was greater than that of downregulated genes (102). In comparison, an *in vitro* transcriptomic analysis of PAMs revealed that only small numbers (no more than 100) of DE genes (threshold of 1.5-fold change) were identified at 1 to 12 hours post PRRSV infection, and the overall effect of PRRSV on the host transcription machinery was downegulation [@B8]. It is not sure whether there is a conversion of the overall effect of PRRSV on host transcription machinery from downregulation to upregulaton as time goes on, or the change is only the effect of the difference between *in vitro* and *in vivo* assays. As compared with the number of DE genes in this study, some thousands of DE genes (threshold of almost 1.5-fold change) were identified in lung tissues at 4 and 7 dpi following both PRRSV and HP-PRRSV infection, by high-throughput deep sequencing assays [@B6], [@B7]. This great number of DE genes might result from the huge amount of data obtained by the deep-sequencing method and from the many cell types in lung tissues.

PRRSV is considered to inhibit the synthesis of type-I IFNs and its signaling by blocking STAT1/STAT2 nuclear translocation [@B35]. However, it is also reported that PRRSV can phosphorylate IFN-regulatory factor 3 (IRF-3) and weakly activate the *IFN-β* promoter in MARC-145 cells in early infection, but the activations of IRF-3 and *IFN-β* promoter are rapidly inhibited in the following infection [@B36]. The induction of *IFN-β* mRNA, but not *IFN-α* mRNA, is observed in monocyte-derived dendritic cells and primary alveolar macrophages infected by PRRSV at 12 dpi [@B8], [@B37]. In some cases, even the expression of *IFN-α* can be detected in the lung [@B38] or serum [@B39] of pigs infected with PRRSV during the early days. Interestingly, in this study, no induction of type-I IFN was detected in PAMs at 5 dpi (Figure [3](#F3){ref-type="fig"}), whereas a series of IFN induced genes that are critical for the cell to defend itself against viral infection, were upregulated (Table [2](#T2){ref-type="table"}). Similar results were shown in lung tissues at 4 and 7 dpi following both PRRSV and HP-PRRSV infection [@B6], [@B7], and it was speculated that the IFN induced genes were predominantly expressed by the uninfected cells [@B7]. Here, another possibility is suggested that a certain amount of type-I IFN might be induced at the early stage of the infection before 5 dpi.

During HP-PRRSV infection, several aspects of the PAMs\' function were under regulation, such as actin and tubulin cytoskeleton organization, exocytosis, protein degradation, protein folding, intracellular calcium and zinc homeostasis (Table [3](#T3){ref-type="table"}). Increasing of intracellular zinc concentration impairs the replication of a variety of RNA viruses, including poliovirus, influenza virus, coronavirus, arterivirus, rhinovirus, and respiratory syncytial virus [@B40]-[@B42]. Recently, zinc ion has been reported to efficiently inhibit the RNA-synthesizing activity of the multiprotein replication and transcription complex of both SARS-coronavirus and equine arteritis virus [@B40]. Upregulation of *SLC39A14* (also known as *Zip14*) (Table [3](#T3){ref-type="table"}), a member of the *SLC39* (*Zip*) family which transports zinc from the extracellular space or organellar lumen into the cytoplasm [@B43], might be a defense mechanism in PAMs during HP-PRRSV infection. Nevertheless, none of the *SLC39* family genes was identified as a DE gene in a microarray assay of PAMs infected with PRRSV *in vitro* [@B8]. Furthermore, the expression of *SLC39A7*, another member of the *SLC39* family, was downregulated in the lungs of Landrace×Yorkshire crossbred piglets at 7 dpi following HP-PRRSV infection [@B7].

It has been shown in this study, that modulated inflammatory reaction, with a few proinflammatory cytokines upregulated (*CCL2*, *CCL4L* and its receptor *CCR5*, and *CSF1*) (Table [4](#T4){ref-type="table"}), might contribute to the mild regional lung lesion observed at 5 and 7 dpi (Figure [1](#F1){ref-type="fig"}C and D). Besides, the complement system is one of the key players in the defense against infections. However, excessive activation of the complement can also exaggerate the disease induced by viral or bacterial infection. In 2009, a new H1N1 influenza A virus caused severe disease in naive middle-aged human individuals with preexisting immunity against seasonal strains, and this disease is reported to be induced through high titers of low-avidity nonprotective antibody and immune complex-mediated complement activation in the respiratory tract [@B44]. Excessive complement activation can contribute to organ damage in combination with the cytokine storm in the later stages of sepsis caused by bacterial infection [@B45]. It is reported that blocking complement activation can ameliorate hepatic inflammation mediated by the hepatitis C virus core protein [@B46]. Likewise, inhibition of complement with a potent C3 inhibitor (compstatin) in a baboon model of late-stage sepsis markedly improves organ preservation and other clinical parameters [@B47]. As it has been shown here, inhibition of the complement system might also be a contributor to the mild regional lung damage during HP-PRRSV infection. Interestingly, infection of HP-PRRSV in six-week-old crossbred weaned pigs (Landrace × Yorkshire) induces complement activation accompanied by severe lung damage [@B7].

Conclusions
===========

In summary, the data presented in this study suggested that during infection with HP-PRRSV Tongcheng piglets exhibited typical clinical signs, but displayed mild regional lung damage at 5 and 7 dpi. Microarray analysis revealed that HP-PRRSV infection has affected PAMs *in vivo* in expression of the important genes involved in cytoskeleton and exocytosis organization, protein degradation and folding, intracellular calcium and zinc homeostasis. Several potential antiviral strategies might be employed in PAMs, including upregulating IFN-induced genes and increasing intracellular zinc ion concentration. Furthermore, inhibition of the complement system likely attenuated the lung damage during HP-PRRSV infection. This system analysis could lead to a better understanding of the HP-PRRSV-host interaction, and to the identification of novel antiviral therapies and identifying genetic components for swine tolerance/susceptibility to HP-PRRS.
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Differentially expressed (DE) genes. 321 DE genes identified under the threshold of fold change (FC) of 1.5 or greater and a false discovery rate (FDR) of approximately 0.5%.

###### 

Click here for additional data file.

###### 
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![**Laboratory infection of Tongcheng piglets with HP-PRRSV.** A: Rectal temperature of the piglets; B: Viral copy numbers per ml serum determined by absolute real-time quantitative PCR; C: Lung morphology of piglets slaughtered at 0, 5 or 7 dpi; D: Gross lung lesion scores of the piglets. The scores of 0 to 100 denote the different severity of gross lung lesion, from intact to totally damaged; E and F: Paraffin sections of the apex of lung at 0 dpi (E) and 5 dpi (F), stained with hematoxylin and eosin. Scale bars indicate 50 μm.](ijbsv07p0947g01){#F1}

![**Microarray analysis of PAMs\' transcriptional responses to HP-PRRSV infection.** A: Hierarchical clustering analysis of gene expression profiles pre- and post-infection. Each column represents one piglet, and each horizontal line refers to a gene. Color legend is on the top-left of the figure. Red indicates genes with a greater expression relative to the geometrical means, green indicates genes with a lower expression relative to the geometrical means; B: Biological process Gene Ontology (GO) analysis of 166 differentially expressed genes. Many categories shared the same transcripts.](ijbsv07p0947g02){#F2}

![**Sensing the HP-PRRSV infection by host cell.**PRRSV enters early endosomes but does not continue through the endocytic pathway to late endosomes [@B48]. The *ATP6V1B2* gene, which encodes a component of vacuolar ATPase (V-ATPase) that mediates acidification of endosomal organelles [@B23], facilitates the uncoating of the virus. Viral nucleic acids could be sensed by Toll-like receptors (TLRs) pathway or RIG-I pathway both of which lead to type-I IFN induction by activating IRF3 and IRF7, and to inflammatory cytokines expression by activating the MAPK signaling pathway. Several IFN-induced genes were upregulated during HP-PRRSV infection, even though no induction of type-I IFN was observed. Red background in the gene box indicates upregulation of the gene expression, green indicates downregulation, and white indicates no change of the gene expression. Fold changes of the differentially expressed genes are 1.94 (*ATP6V1B2*), 0.31 (*SARM1*), 4.58 (*IRF7*), 1.79 (*SOCS1*), 1.59 (*SBNO2*), 1.81 (*NMI*), and 2.48 (*STAT1*), respectively.](ijbsv07p0947g03){#F3}

![**Q-PCR validation of the microarray data.** P values (T-test) of the Q-PCR data are 0.018 (*CCL2*), 0.039 (*SLC39A14*), 0.044 (*DDIT3*), 0.006 (*GLRX2*), 0.008 (*ATP6V1B2*), 0.508 (*TNF*) and 0.032 (*C3*), respectively. *TNF* is a non-differentially expressed gene.](ijbsv07p0947g04){#F4}

###### 

Primers used for Q-PCR validation

  Gene         Primer sequence (5\'-3\')                                           Target size (bp)   Tm (℃)^a^
  ------------ ------------------------------------------------------------------- ------------------ -----------
  *C3*         Forward: AAACTAAAGGAGGGGGGACACT Reverse: CTTGGCATACATCACCATCAGG     133                60
  *CCL2*       Forward: AACTTGCCCTAAATACCCTCAGA Reverse: GGAAAGCAATGTGCCCAAGTC     179                61
  *DDIT3*      Forward: ACGGCTCAAGCAGGAAATC Reverse: CACTGGTAAGAAGGTGGTTGGT        173                58
  *EMP1*       Forward: CTCAGATGCGGGACAAGGA Reverse: AAGACCACGAGGGAGACGA           156                58
  *GLRX2*      Forward: TACGGAAGCCAGTTTCAAGAC Reverse: CTTGGTGAAGCCTATGAGTGTC      118                58
  *TNF*        Forward: CATCGCCGTCTCCTACCA Reverse: CCCAGATTCAGCAAAGTCCA           199                58
  *RPL32*^b^   Forward: CGGAAGTTTCTGGTACACAATGTAA Reverse: TGGAAGAGACGTTGTGAGCAA   94                 58-61

^a^The annealing temperature represents the optimal temperature during quantitative PCR;

^b^RNA levels of *RPL32* was assayed for normalization during quantitative PCR.

###### 

Interferon induced genes

  Gene symbol   Gene description                                                                     Affymetrix probe set ID   Fold Change
  ------------- ------------------------------------------------------------------------------------ ------------------------- -------------
  *GBP1*        guanylate binding protein 1, interferon-inducible, 67kDa                             Ssc.29054.1.A1_at         3.51
  *GBP2*        guanylate binding protein 2, interferon-inducible                                    Ssc.883.1.S1_a\_at        4.32
  *GZMB*        granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)         Ssc.4939.2.S1_at          19.07
  *GZMH*        granzyme H (cathepsin G-like 2, protein h-CCPX)                                      Ssc.25976.1.S1_at         4.75
  *IFI16*       interferon, gamma-inducible protein 16                                               Ssc.10884.1.A1_at         3.41
  *IFI6*        Interferon, alpha-inducible protein 6                                                Ssc.20101.1.S1_at         4.34
  *IFIH1*       interferon induced with helicase C domain 1                                          Ssc.17894.1.A1_at         3.53
  *IFIT2*       interferon-induced protein with tetratricopeptide repeats 2                          Ssc.22620.1.S1_at         6.16
  *IFIT3*       interferon-induced protein with tetratricopeptide repeats 3                          Ssc.31140.1.S1_at         4.17
  *IFITM3*      interferon induced transmembrane protein 3 (1-8U)                                    Ssc.30956.1.A1_s\_at      6.05
  *ISG15*       ISG15 ubiquitin-like modifier                                                        Ssc.11557.1.A1_at         7.89
  *MX1*         myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse)   Ssc.221.1.S1_at           4.45
  *NMI*         N-myc (and STAT) interactor                                                          Ssc.9572.1.A1_at          1.81
  *RSAD2*       radical S-adenosyl methionine domain containing 2                                    Ssc.286.1.S1_s\_at        9.74
  *USP18*       ubiquitin specific peptidase 18                                                      Ssc.336.1.S1_at           3.1

###### 

DE genes and their relation to different aspects of the host cell organization

  Gene symbol                          Gene description                                                                                 Affymetrix probe set ID   Fold Change
  ------------------------------------ ------------------------------------------------------------------------------------------------ ------------------------- -------------
  Cytoskeleton                                                                                                                                                    
  *S100A6*                             S100 calcium binding protein A6                                                                  Ssc.21109.1.S1_a\_at      4.87
  *MARCKS*                             MARCKS-like 1                                                                                    Ssc.1228.1.S1_at          3.00
  *CACYBP*                             calcyclin binding protein                                                                        Ssc.10299.1.A1_at         2.28
  *CCT6A*                              chaperonin containing TCP1, subunit 6A (zeta 1)                                                  Ssc.11348.1.A2_at         2.06
  *ARHE*                               Rho family GTPase 3                                                                              Ssc.4127.2.A1_at          1.87
  *CCT3*                               chaperonin containing TCP1, subunit 3 (gamma                                                     Ssc.902.1.S1_a\_at        1.71
  *PTPN4*                              protein tyrosine phosphatase, non-receptor type 4 (megakaryocyte)                                Ssc.29697.1.A1_at         1.70
  *CCT7*                               chaperonin containing TCP1, subunit 7 (gamma                                                     Ssc.11002.1.S1_at         1.64
  *TWF1*                               twinfilin, actin-binding protein, homolog 1 (Drosophila)                                         Ssc.7177.1.A1_at          1.57
  *RASSF8*                             Ras association (RalGDS/AF-6) domain family (N-terminal) member                                  Ssc.15288.1.S1_at         0.64
  *ELMO1*                              engulfment and cell motility 1                                                                   Ssc.5648.1.A1_at          0.63
  *KIF11*                              kinesin family member 11                                                                         Ssc.30748.1.S1_at         0.40
  Exocytosis and vesicle trafficking                                                                                                                              
  *RSAD2*                              radical S-adenosyl methionine domain containing 2                                                Ssc.286.1.S1_s\_at        9.74
  *GSK3B*                              glycogen synthase kinase 3 beta                                                                  Ssc.30917.1.A1_at         3.09
  *LMAN2L*                             lectin, mannose-binding 2-like                                                                   Ssc.24211.1.S1_at         1.71
  *EXOC2*                              exocyst complex component 2                                                                      Ssc.7976.1.A1_at          1.71
  *SELS*                               selenoprotein S                                                                                  Ssc.2739.1.S1_at          1.71
  *COPZ2*                              coatomer protein complex, subunit zeta 2                                                         Ssc.4221.1.S1_at          0.49
  *SEC31L2*                            SEC31 homolog B (S. cerevisiae)                                                                  Ssc.31182.1.A1_at         0.43
  *SEC8L1*                             exocyst complex component 4                                                                      Ssc.9822.1.A1_at          0.25
  Ubiquitination and ISGylation                                                                                                                                   
  *ISG15*                              ISG15 ubiquitin-like modifier                                                                    Ssc.11557.1.A1_at         7.89
  *USP18*                              ubiquitin specific peptidase 18                                                                  Ssc.336.1.S1_at           3.10
  *CACYBP*                             calcyclin binding protein                                                                        Ssc.10299.1.A1_at         2.28
  *HERPUD1*                            homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1   Ssc.12017.1.A1_at         2.06
  *CUL1*                               cullin 1                                                                                         Ssc.30295.1.A1_at         1.60
  *HERC6*                              hect domain and RLD 6                                                                            Ssc.26483.1.A1_at         1.66
  *HERC3*                              hect domain and RLD 3                                                                            Ssc.9737.1.S1_at          0.39
  *G2E3*                               G2/M-phase specific E3 ubiquitin protein ligase                                                  Ssc.7317.1.A1_at          0.58
  *UBASH3B*                            ubiquitin associated and SH3 domain containing B                                                 Ssc.25139.3.S1_at         0.35
  Chaperones                                                                                                                                                      
  *NPM3*                               nucleophosmin/nucleoplasmin 3                                                                    Ssc.6196.1.S1_at          2.23
  *CCT3*                               chaperonin containing TCP1, subunit 3 (gamma                                                     Ssc.902.1.S1_a\_at        1.71
  *CCT7*                               chaperonin containing TCP1, subunit 7 (gamma                                                     Ssc.11002.1.S1_at         1.64
  *CCT6A*                              chaperonin containing TCP1, subunit 6A (zeta 1)                                                  Ssc.11348.1.A2_at         2.06
  *DNAJA1*                             DnaJ (Hsp40) homolog, subfamily A, member 1                                                      Ssc.8473.1.S2_at          2.03
  *DNAJA4*                             DnaJ (Hsp40) homolog, subfamily A, member 4                                                      Ssc.17243.1.S1_at         11.31
  *DNAJB1*                             DnaJ (Hsp40) homolog, subfamily B, member 1                                                      Ssc.3502.1.S1_at          3.46
  *DNAJB2*                             DnaJ (Hsp40) homolog, subfamily B, member 2                                                      Ssc.1180.1.S1_at          1.54
  *DNAJB4*                             DnaJ (Hsp40) homolog, subfamily B, member 4                                                      Ssc.13345.1.A1_at         8.78
  *HSPA1B*                             heat shock 70kDa protein 1A                                                                      Ssc.5145.1.S1_at          4.44
  *HSPA4*                              Heat shock 70kDa protein 4                                                                       Ssc.3313.1.S1_at          2.46
  *HSPA4*                              heat shock 70kDa protein 4                                                                       Ssc.11197.1.S1_at         1.98
  *HSPA6*                              heat shock 70kDa protein 6 (HSP70B\')                                                            Ssc.6728.1.S1_at          1.60
  *HSPD1*                              heat shock 60kDa protein 1 (chaperonin)                                                          Ssc.6719.1.A1_at          1.83
  *HSPH1*                              heat shock 105kDa/110kDa protein 1                                                               Ssc.1231.1.A1_at          2.94
  Intracellular calcium homeostasis                                                                                                                               
  *CKM*                                creatine kinase, muscle                                                                          Ssc.415.1.S1_at           9.13
  *KLB*                                klotho beta                                                                                      Ssc.7252.1.A1_at          2.77
  *HERPUD1*                            homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1   Ssc.12017.1.A1_at         2.06
  *TRPM4*                              transient receptor potential cation channel, subfamily M, member 4                               Ssc.10022.1.A1_at         1.81
  *HAX1*                               HCLS1 associated protein X-1                                                                     Ssc.6188.1.S1_at          1.79
  *PIK3C2A*                            phosphoinositide-3-kinase, class 2, alpha polypeptide                                            Ssc.29061.1.A1_at         0.58
  *PIK3R2*                             phosphoinositide-3-kinase, regulatory subunit 2 (beta)                                           Ssc.1677.1.A1_at          0.47
  Zinc ion signaling                                                                                                                                              
  *SLC39A14*                           solute carrier family 39 (zinc transporter), member 14                                           Ssc.19143.1.A1_at         5.06
  *ZDHHC9*                             zinc finger, DHHC-type containing 9                                                              Ssc.16227.1.S1_at         16.57
  *ZFAND2A*                            zinc finger, AN1-type domain 2A                                                                  Ssc.5082.1.A1_at          2.75
  *ZCCHC6*                             zinc finger, CCHC domain containing 6                                                            Ssc.21294.1.S1_at         2.21
  *ZCWPW1*                             zinc finger, CW type with PWWP domain 1                                                          Ssc.31003.1.A1_at         2.04
  *ZFP2*                               ZFP2 zinc finger protein 2 homolog                                                               Ssc.7514.1.A1_at          1.84
  *ZNF258*                             zinc finger, MYM-type 6                                                                          Ssc.17765.1.S1_at         0.50

###### 

DE genes and their relation to tissue remolding and inflammation

  Gene symbol                               Gene description                                                                Affymetrix probe set ID   Fold Change
  ----------------------------------------- ------------------------------------------------------------------------------- ------------------------- -------------
  Extracellular matrix homeostasis                                                                                                                    
  *TIMP1*                                   TIMP metallopeptidase inhibitor 1                                               Ssc.11784.1.S1_at         4.48
  *PLOD1*                                   procollagen-lysine 1, 2-oxoglutarate 5-dioxygenase 1                            Ssc.3530.1.A1_at          3.74
  *CSPG2*                                   versican                                                                        Ssc.5663.1.S1_at          3.19
  *ADAMTSL3*                                ADAMTS-like 3                                                                   Ssc.11976.1.A1_at         2.72
  *LAMC1*                                   laminin, gamma 1 (formerly LAMB2)                                               Ssc.1099.1.S1_at          2.46
  *ADAMTS20*                                ADAM metallopeptidase with thrombospondin type 1 motif, 20                      Ssc.29491.1.A1_at         2.40
  *ST14*                                    suppression of tumorigenicity 14 (colon carcinoma)                              Ssc.3285.1.S1_at          1.84
  *MMP28*                                   matrix metallopeptidase 28                                                      Ssc.29059.1.A1_at         0.53
  *NDST4*                                   N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 4                       Ssc.13434.2.A1_at         0.49
  *TGFBI*                                   transforming growth factor, beta-induced, 68kDa                                 Ssc.16671.1.S1_at         0.36
  Vascular permeability                                                                                                                               
  *LRP11*                                   low density lipoprotein receptor-related protein 11                             Ssc.14282.1.A1_at         4.37
  *LRP8*                                    low density lipoprotein receptor-related protein 8, apolipoprotein e receptor   Ssc.31016.1.A1_at         3.29
  *SELL*                                    selectin L                                                                      Ssc.22075.3.A1_at         2.97
  *SCPEP1*                                  serine carboxypeptidase 1                                                       Ssc.3037.3.A1_at          2.21
  *ANGPTL4*                                 angiopoietin-like 4                                                             Ssc.8980.1.A1_at          0.51
  *PLVAP*                                   plasmalemma vesicle associated protein                                          Ssc.3645.1.S1_at          0.19
  Complement system                                                                                                                                   
  *CLU*                                     clusterin                                                                       Ssc.11992.1.A1_at         14.52
  *PFC*                                     complement factor properdin                                                     Ssc.27474.1.S1_at         0.49
  *C3*                                      complement component 3                                                          Ssc.61.1.S1_at            0.29
  Immune cells recruitment and activation                                                                                                             
  *CCL2*                                    chemokine (C-C motif) ligand 2                                                  Ssc.657.1.A1_at           14.17
  *CSF1*                                    colony stimulating factor 1 (macrophage)                                        Ssc.6369.1.A1_at          6.71
  *CCL4L*                                   chemokine (C-C motif) ligand 4-like 1                                           Ssc.23797.1.S1_at         4.86
  *CLECL1*                                  C-type lectin-like 1                                                            Ssc.12825.1.A1_at         2.66
  *IL1RAP*                                  interleukin 1 receptor accessory protein                                        Ssc.7864.1.A1_at          2.49
  *CCR5*                                    chemokine (C-C motif) receptor 5                                                Ssc.26328.1.S1_at         2.20
  *MPP1*                                    membrane protein, palmitoylated 1, 55kDa                                        Ssc.19356.1.S1_at         0.57
  *PPBP*                                    pro-platelet basic protein (chemokine (C-X-C motif) ligand 7)                   Ssc.16228.1.S1_at         0.39
  *PF4*                                     platelet factor 4 (chemokine (C-X-C motif) ligand 4)                            Ssc.24188.1.A1_at         0.35
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